Skip navigation
Full metadata record
DC FieldValueLanguage
dc.contributor.authorArmony, Mor-
dc.contributor.authorPlambeck, Erica-
dc.contributor.authorSeshadri, Sridhar-
dc.date.accessioned2006-04-04T14:21:26Z-
dc.date.available2006-04-04T14:21:26Z-
dc.date.issued2005-
dc.identifier.urihttp://hdl.handle.net/2451/14637-
dc.description.abstractWe use sample path arguments to derive convexity properties of an M/M/S queue with impatient customers that balk and renege. First, assuming that the balking probability and reneging rate are increasing and concave in the total number of customers in the system (head-count), we prove that the expected head-count is convex decreasing in the capacity (service rate). Second, with linear reneging and balking, we show that the expected lost sales rate is convex decreasing in the capacity. Finally, we employ a sample-path sub-modularity approach to comparative statics. That is, we employ sample path arguments to show how the optimal capacity changes as we vary the parameters of customer demand and impatience. We find that the optimal capacity increases in the demand rate and decreases with the balking probability, but is not monotone in the reneging rate. This means, surprisingly, that failure to account for customersâ reneging may result in over-investment in capacity. Finally, we show that a seemingly minor change in system structure, customer commitment during service, produces qualitatively different convexity properties and comparative statics.en
dc.format.extent228673 bytes-
dc.format.mimetypeapplication/pdf-
dc.languageEnglishEN
dc.publisherStern School of Business, New York Universityen
dc.relation.ispartofseriesOM-2005-09en
dc.titleConvexity Properties and Comparative Statics for M/M/S Queues with Balking and Renegingen
dc.typeWorking Paperen
dc.description.seriesOperations Management Working Papers SeriesEN
Appears in Collections:IOMS: Operations Management Working Papers

Files in This Item:
File Description SizeFormat 
OM-2005-9.pdf223.31 kBAdobe PDFView/Open


Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.